Literature DB >> 28649799

Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms.

Brian C Jordan1, Bhavna Kumar2, Ramasamy Thilagavathi3, Arti Yadhav2, Pawan Kumar2, Chelliah Selvam1.   

Abstract

Curcumin is a popular, plant-derived compound that has been extensively investigated for diverse range of biological activities. Anticancer activity against various types of cancers and high-safety profile associated with curcumin makes it very attractive. In this study, we report the synthesis and evaluation of pyrazole and click chemistry curcumin analogues for Head and Neck cancer. MTT assay against head and neck cancer cell lines CAL27 and UM-SCC-74A revealed the micromolar potency of the synthesized compounds. To determine the possible molecular mechanisms, effect of these analogues in the expression of pSTAT3, pFAK, pERK1/2 and pAKT was studied. Interestingly, compounds 2 and 5 significantly inhibited the pSTAT3 (Tyr 705) phosphorylation. As far as other compounds, they showed potent cytotoxicity against CAL27; however, these compounds did not show any activity on pSTAT3 phosphorylation at IC50 concentration level. Molecular docking studies revealed the possible binding mode of pyrazole compound 2 in the SH2 domain of STAT3.
© 2017 John Wiley & Sons A/S.

Entities:  

Keywords:  click chemistry curcumin analogue; curcumin; head and neck squamous cell carcinoma; pyrazole analogue

Mesh:

Substances:

Year:  2017        PMID: 28649799      PMCID: PMC5942545          DOI: 10.1111/cbdd.13061

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  30 in total

1.  Performance evaluation of structure based and ligand based virtual screening methods on ten selected anti-cancer targets.

Authors:  Thilagavathi Ramasamy; Chelliah Selvam
Journal:  Bioorg Med Chem Lett       Date:  2015-08-20       Impact factor: 2.823

2.  FRED pose prediction and virtual screening accuracy.

Authors:  Mark McGann
Journal:  J Chem Inf Model       Date:  2011-02-16       Impact factor: 4.956

3.  Conformer generation with OMEGA: learning from the data set and the analysis of failures.

Authors:  Paul C D Hawkins; Anthony Nicholls
Journal:  J Chem Inf Model       Date:  2012-11-12       Impact factor: 4.956

4.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

Review 5.  Curcumin-based anti-prostate cancer agents.

Authors:  Qiao-Hong Chen
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

6.  A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation.

Authors:  Xiaolei Zhang; Ying Sun; Roberta Pireddu; Hua Yang; Murali K Urlam; Harshani R Lawrence; Wayne C Guida; Nicholas J Lawrence; Saïd M Sebti
Journal:  Cancer Res       Date:  2013-01-15       Impact factor: 12.701

7.  Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.

Authors:  Alen N Cohen; Mysore S Veena; Eri S Srivatsan; Marilene B Wang
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-02

8.  Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin.

Authors:  Soumyananda Chakraborti; Gopa Dhar; Vishnu Dwivedi; Amlan Das; Asim Poddar; Gopal Chakraborti; Gautam Basu; Pinak Chakrabarti; Avadhesha Surolia; Bhabatarak Bhattacharyya
Journal:  Biochemistry       Date:  2013-10-10       Impact factor: 3.162

Review 9.  Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature.

Authors:  Preetha Anand; Sherin G Thomas; Ajaikumar B Kunnumakkara; Chitra Sundaram; Kuzhuvelil B Harikumar; Bokyung Sung; Sheeja T Tharakan; Krishna Misra; Indira K Priyadarsini; Kallikat N Rajasekharan; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2008-08-19       Impact factor: 5.858

10.  Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.

Authors:  Rubing Wang; Xiaojie Zhang; Chengsheng Chen; Guanglin Chen; Qiu Zhong; Qiang Zhang; Shilong Zheng; Guangdi Wang; Qiao-Hong Chen
Journal:  Eur J Med Chem       Date:  2016-01-21       Impact factor: 6.514

View more
  3 in total

1.  Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties.

Authors:  Aladdin M Srour; Siva S Panda; Ahmed Mostafa; Walid Fayad; May A El-Manawaty; Ahmed A F Soliman; Yassmin Moatasim; Ahmed El Taweel; Mohamed F Abdelhameed; Mohamed S Bekheit; Mohamed A Ali; Adel S Girgis
Journal:  Bioorg Chem       Date:  2021-11-04       Impact factor: 5.275

Review 2.  Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues.

Authors:  Adeoluwa Adeluola; Abu Hasanat Md Zulfiker; Daniel Brazeau; A R M Ruhul Amin
Journal:  Eur J Pharmacol       Date:  2021-06-17       Impact factor: 5.195

3.  The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.

Authors:  Felipe Teixeira Lima; Viviane Seba; Gabriel Silva; Guilherme Silva Torrezan; Carlos Roberto Polaquini; Vitor Caressato Pinhanelli; Seung J Baek; Ana Lúcia Fachin; Luis Octavio Regasini; Mozart Marins
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.